US Federal Trade Commission Sues CVS Health, Cigna, UnitedHealth's Pharmacy Benefit Managers For Inflating Insulin Prices
On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers (PBMs)—CVS Health Inc’s (NYSE:CVS) Caremark, Cigna Corp’s (NYSE:CI) Express Scripts,
UnitedHealth, Cigna, CVS PBMs targeted by FTC over inflated insulin prices
The Federal Trade Commission has brought an administrative complaint against three of the country's largest pharmacy benefit managers (PBMs), accusing them of engaging in practices that artificially inflated the list price of insulin drugs.
This was the stock's second consecutive day of losses.
Zacks.com on MSN1d
Investors Heavily Search UnitedHealth Group Incorporated (UNH): Here is What You Need to KnowUnitedHealth Group (UNH) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some ...
With expansion into targeted markets and strategic diversification, UNH still has significant growth potential left.
UnitedHealth Group Inc. closed $30.87 below its 52-week high ($607.94), which the company achieved on September 4th.
We recently compiled a list of the 12 Best Forever Stocks To Buy Now. In this article, we are going to take a look at where ...
The majority of cuts will take place in December, according to a notice filed with the state of New Jersey this month.
UnitedHealth Group Inc. struck a tentative deal to settle a class action challenging the Wells Fargo & Co. target date funds ...
UnitedHealth Group’s (NYSE:UNH) acquisition of Amedisys (Nasdaq:AMED) is still pending. That could be due to a variety of factors, but one is clear: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback